Millicent Pharma, a specialty pharmaceutical company focused on women's health, has announced a multimillion-dollar investment in its Larne manufacturing facility, alongside the creation of more than 20 new local high-quality jobs at the site.

The investment will support automation and productivity improvements at Larne, strengthening the company's manufacturing capabilities and innovation while enabling it to respond to growing demand for its products.

Specialty Pharma Firm Expands Larne Operations

The planned expansion will increase the Larne workforce from 50 to 70 employees. Recruitment will span a range of positions, including technicians, managers, supervisors, engineers, and quality assurance specialists.

Capital investment has already commenced and will continue over the next few years, with recruitment for the new roles actively underway following job postings published in early October.

Company Background and Regional Footprint

Millicent Pharma is a fully integrated pharmaceutical company that develops, manufactures, and sells branded women's health therapies, including contraception and hormone replacement therapy. Its operations span manufacturing, research and development, and corporate functions across the UK, Ireland, the US, and Puerto Rico.

Established in 2018 with financial backing from the Carlyle Group and its founders, the company operates manufacturing facilities in Larne and Puerto Rico, alongside corporate offices in Dundalk, Ireland, and New Jersey, USA. Invest Northern Ireland has previously supported the company's growth in the region.

The Larne facility serves as both a manufacturing base and a dedicated R&D Centre of Excellence, playing an important role in the region's life sciences and pharmaceutical sector.

Leadership Comments on the Expansion

Ryan Loughlin, Senior Vice-President of Millicent Pharma, said the company was delighted to announce its expansion plans in Larne.

Having been part of the local economy for seven years, he described the announcement as a tangible demonstration of the company's commitment to investing in both its production capabilities and job creation, which he called collectively a meaningful contribution to the region's prosperity.

Loughlin added that the team at Millicent Pharma are equally passionate about the company's research and development within women's health and about supporting Larne's community wealth-building initiatives, and that the company looks forward to seeing the impact the major capital investment will have both on the local economy and on women's health globally.

Community Wealth Building Partnership

As part of its commitment to the area, Millicent Pharma is a supporter of the Larne Community Wealth Building Partnership, a programme led by LEDCOM.

Ken Nelson, CEO of LEDCOM and Chairman of the Larne Community Wealth Building Partnership, said that as a vital part of the Larne life and health sciences sector, it is exciting to witness Millicent Pharma's growth plans as it progresses towards being a global centre of excellence within its target markets.

He noted that the company's ongoing investment plans will create attractive new employment and skills opportunities for the local area.

Loughlin also emphasised the connection between the company and the town, saying that Millicent Pharma's future and Larne's future are closely linked.

Supporting the Community Wealth Building Partnership, he said, is about ensuring that as the company grows, the benefits, skills, jobs, and opportunities are shared across the whole locality.

Don't Let the United Kingdom's Next Big Industrial Project Pass You By

The United Kingdom's industrial sector is undergoing a historic transformation; green steel plants, gigafactories, and hydrogen hubs are being planned, tendered, and built right now. The question is, how early are you hearing about them?

Staying ahead of the competition requires more than press releases and word of mouth. It demands a continuous, structured view of project pipelines, procurement activity, and contract movements across every major industrial market in the United Kingdom.

The Global Project Tracking (GPT) platform by Blackridge Research gives you exactly that, real-time intelligence on industrial projects from early planning stages through commissioning, so your team can act on opportunities months before they become public knowledge.

• Upcoming Projects

• Tender Notices

• Contract Awards

• Projects Under Construction

• Completed Projects

Ready to see the entire United Kingdom industrial project landscape at a glance? Book a Free Demo today and discover how the Global Project Tracking (GPT) platform by Blackridge Research can sharpen your competitive edge.